Visual Erotica, EMG, and Sexual Psychophysiological Arousal (VESPA)
NCT ID: NCT01700361
Last Updated: 2017-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15 participants
OBSERVATIONAL
2012-10-31
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Utilization of the Mirror During Pelvic Exams
NCT03785548
MRI & MRV in Pelvic Congestion Syndrome in Females
NCT03252041
The Effect Of Pelvic Floor Muscle Training With Biofeedback And Extracorporeal Magnetic Innervation On The Urinary Symptoms, Sexual Function And Quality Of Life
NCT03875196
Ultrasound and Pelvic Floor Muscle Training
NCT04361890
Best Verbal Instruction to Obtain Voluntary Pelvic Floor Muscle Contraction
NCT03272386
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Investigators hypothesize that, relative to the neutral films, PFM EMG activity will significantly increase in response to the erotic film as measured by the labial, anal, and vaginal EMG probes.
2. Investigators hypothesize that, relative to the anxiety-provoking film, PFM EMG activity will significantly increase in response to the erotic film as measured by the labial, anal, and vaginal EMG probes.
3. Investigators hypothesize that continuously measured subjective sexual arousal (via the arousometer) will correlate significantly with PFM EMG activity during the erotic film.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No treatment
This is an observational study. Women in this study are not receiving any treatments.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be premenopausal
* Must be previously sexually active
* Must be fluent in English
Exclusion Criteria
* Not female between the ages of 19-45
* Not previously sexually active
* Any previous deliveries, either vaginal or by c-section
* Any sexual arousal disorder
* Any genital pain or pelvic pain disorders
* Any bowel or bladder syndromes (e.g. interstitial cystitis, irritable bowel disease, Chron's disease)
* Any urinary incontinence or pelvic organ prolapse
* Undergone medically induced menopause
* Undergone total or partial hysterectomy
* Undergone surgery for incontinence or prolapse
* Using estrogen suppression medication
19 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lori Brotto
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lori A. Brotto, PhD
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Gynaecology
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
UBC Sexual Health Lab Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H12-01852
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.